Edinburgh University medical technology spin-out i2Eye Diagnostics has secured £600,000 in new funding to promote the marketing of revolutionary sight-testing technology after securing approval from regulators.
The company, launched in 2010 and based in the Edinburgh BioQuarter, has pioneered a "fail-safe" way to assess the field of vision of hard-to-test groups such as children and the physically impaired. Such testing is key to diagnosing optical and neurological abnormalities, but is difficult with patients unable to suppress reflexes or give responses.
We moderate all comments on HeraldScotland on either a pre-moderated or post-moderated basis. If you're a relatively new user then your comments will be reviewed before publication and if we know you well then your comments will be subject to moderation only if other users or the moderators believe you've broken the rules, which are available here.
Moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours. Please be patient if your posts are not approved instantly.
